Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-02

Clinical Trial Update: Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms [Phase 4]

View source ↗

Summary

The document reports the completion and results of a Phase 4 pilot trial evaluating urinary nerve growth factor (NGF) as a biomarker for male lower urinary trac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Timothy Boone, MD, PhD | Conditions: Lower Urinary Tract Symptoms | Phase 4 | Status: COMPLETED | Results posted: 2018-04-02